Clinical Trial

Study on Heart Failure with Preserved Ejection Fraction with Qishen Granules

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
With the cardiopulmonary exercise testing as the primary outcome, the study aims to evaluate the efficacy of Qishen Granules on cardiac function, quality of life and biomarker level of patients with heart failure with preserved ejection fraction (HFpEF), which will provide evidence for the treatment of HFpEF with traditional Chinese medicine.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-17.
Trial Details
NCT Number NCT06377761
Lead Sponsor Guangdong Provincial Hospital of Traditional Chinese Medicine
Conditions Heart Failure with Preserved Ejection Fraction
Enrollment 80 participants
Start Date 2023-05-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-18